Low SHIP1 activity was associated with acute myeloid leukemia (AML) [3], acute lymphoblastic leukemia (ALL) [4], and chronic myeloid leukemia (CML) [5]. Here, INPP5D is linked to chronic myelogenous leukemia, BCR-ABL1 positive.